Track the MusclePharm Corp share price and the full insider trade history of the company, a listed equity based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Operating in the Health Care sector, MusclePharm Corp has published 6 reports. The latest transaction was filed on 31 March 2022 (Cession). Among the most active insiders: White Winston Select Asset Fund Series Fund MP-18, LLC. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
MusclePharm Corp is a company focused on sports nutrition, providing a range of products such as protein powders and supplements. It is listed on NASDAQ under the ticker XNAS.